Association of C677T and A1298C polymorphisms of the MTHFR gene with maternal risk for Down syndrome: a meta-analysis of case-control studies.

[1]  S. Petch,et al.  Folic acid fortification of flour to prevent neural tube defects in Europe - A position statement by the European Board and college of obstetrics and gynaecology (EBCOG). , 2022, European journal of obstetrics, gynecology, and reproductive biology.

[2]  B. Cikota-Aleksic,et al.  Maternal MTHFR 677C>T, 1298A>C gene polymorphisms and risk of offspring aneuploidy , 2022, Prenatal diagnosis.

[3]  Jie Wu,et al.  Association of methylenetetrahydrofolate reductase ( MTHFR ) gene polymorphisms (C677T and A1298C) with thyroid dysfunction: A meta-analysis and trial sequential analysis , 2022, Archives of endocrinology and metabolism.

[4]  A. Kaur,et al.  Role of folate metabolizing genes and homocysteine in mothers of Down syndrome children , 2022, Tzu chi medical journal.

[5]  M. Eberlin,et al.  One-carbon metabolism and global DNA methylation in mothers of individuals with Down syndrome , 2021, Human Cell.

[6]  Ivana Babić Božović,et al.  Methylenetetrahydrofolate Reductase Dimer Configuration as a Risk Factor for Maternal Meiosis I-Derived Trisomy 21 , 2021, Human Heredity.

[7]  M. Choolani,et al.  Fission Yeast Methylenetetrahydrofolate Reductase Ensures Mitotic and Meiotic Chromosome Segregation Fidelity , 2021, International journal of molecular sciences.

[8]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2020, BMJ.

[9]  F. Marchetti,et al.  Mechanisms of oocyte aneuploidy associated with advanced maternal age. , 2020, Mutation research.

[10]  Nasreen J Talib,et al.  Altered Folate Homeostasis in Children with Down Syndrome: A Potential Basis for Enhanced Methotrexate Toxicity. , 2020, The Journal of pediatrics.

[11]  S. Antonarakis,et al.  Down syndrome , 2020, Nature Reviews Disease Primers.

[12]  Anirban Ray,et al.  Polymorphisms of folate metabolism regulators increase risk of meiosis II nondisjunction of chromosome 21 in oocyte , 2019 .

[13]  T. Dobosz,et al.  Polymorphisms of the MTHFR gene in mothers of children with trisomy 21 (Down syndrome) in a Polish population. , 2019, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

[14]  D. Chandel,et al.  MTHFR gene polymorphism and associated nutritional deficiency in the etiology and pathogenesis of Down syndrome , 2019, Egyptian Journal of Medical Human Genetics.

[15]  W. Ying,et al.  Genetic polymorphisms in folate metabolism as risk for Down syndrome in the southern China , 2019, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[16]  Y. Zhang,et al.  The association between maternal methylenetetrahydrofolate reductase C677T and A1298C polymorphism and birth defects and adverse pregnancy outcomes , 2018, Prenatal diagnosis.

[17]  Ayfer Pazarbaşı,et al.  Türk populasyonunda maternal MTHFR geni polimorfizmleri ve Down sendromlu çocuk sahibi olma riski , 2018 .

[18]  Di Yu,et al.  MTHFR A1298C polymorphisms reduce the risk of congenital heart defects: a meta-analysis from 16 case-control studies , 2017, Italian Journal of Pediatrics.

[19]  M. Balarin,et al.  Screening of six polymorphisms related with folate metabolism in parents of individuals with Down syndrome , 2017, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[20]  J. Breda,et al.  Adult Nutrient Intakes from Current National Dietary Surveys of European Populations , 2017, Nutrients.

[21]  Y. Kagawa,et al.  Genetic polymorphisms and folate status , 2017, Congenital anomalies.

[22]  F. Coppedè.  Risk factors for Down syndrome , 2016, Archives of Toxicology.

[23]  B. Wang,et al.  Application of the Key Events Dose-response Framework to Folate Metabolism , 2016, Critical reviews in food science and nutrition.

[24]  A. Barrett,et al.  Synthetic combinations of missense polymorphic genetic changes underlying Down syndrome susceptibility , 2016, Cellular and Molecular Life Sciences.

[25]  S. Jaiswal,et al.  Role of folate-homocysteine pathway gene polymorphisms and nutritional cofactors in Down syndrome: A triad study. , 2015, Human reproduction.

[26]  F. Coppedè.  The genetics of folate metabolism and maternal risk of birth of a child with Down syndrome and associated congenital heart defects , 2015, Front. Genet..

[27]  A. Stanković,et al.  Altered LINE-1 Methylation in Mothers of Children with Down Syndrome , 2015, PloS one.

[28]  Pradeep Kumar,et al.  Maternal Methylenetetrahydrofolate Reductase C677T Polymorphism and Down Syndrome Risk: A Meta-Analysis from 34 Studies , 2014, PloS one.

[29]  E. Goloni-Bertollo,et al.  Meta-analysis of Methylenetetrahydrofolate reductase maternal gene in Down syndrome: increased susceptibility in women carriers of the MTHFR 677T allele , 2014, Molecular Biology Reports.

[30]  Yukai Du,et al.  Maternal gene polymorphisms involved in folate metabolism and the risk of having a Down syndrome offspring: a meta-analysis. , 2013, Mutagenesis.

[31]  Amandeep Kaur,et al.  Prevalence of methylenetetrahydrofolate reductase 677 C-T polymorphism among mothers of Down syndrome children , 2013, Indian journal of human genetics.

[32]  Ying Luo,et al.  Folate metabolism gene polymorphisms MTHFR C677T and A1298C and risk for Down syndrome offspring: a meta-analysis. , 2013, European journal of obstetrics, gynecology, and reproductive biology.

[33]  Rajender Singh,et al.  Association of maternal and fetal MTHFR A1298C polymorphism with the risk of pregnancy loss: a study of an Indian population and a meta-analysis. , 2013, Fertility and sterility.

[34]  I. Orioli,et al.  Association of methylenetetrahydrofolate reductase gene 677C > T polymorphism and Down syndrome , 2013, Molecular Biology Reports.

[35]  M. Tayeb.  The methylenetetrahydrofolate reductase gene variant (C677T) in risk mothers with Down syndrome among Saudi population , 2012 .

[36]  P. Mohanty,et al.  Evaluation of C677T polymorphism of the methylenetetra hydrofolate reductase gene and its association with levels of serum homocysteine, folate, and vitamin B12 as maternal risk factors for Down syndrome , 2012, Indian journal of human genetics.

[37]  H. Kurahashi,et al.  Molecular basis of maternal age‐related increase in oocyte aneuploidy , 2012, Congenital anomalies.

[38]  E. Goloni-Bertollo,et al.  Maternal Risk for Down Syndrome Is Modulated by Genes Involved in Folate Metabolism , 2012, Disease markers.

[39]  I. Prpić,et al.  MTHFR C677T and A1298C polymorphisms as a risk factor for congenital heart defects in Down syndrome , 2011, Pediatrics international : official journal of the Japan Pediatric Society.

[40]  Amjad D. Al-Nasser,et al.  Methylenetetrahydrofolate reductase polymorphisms C677T and A1298C as maternal risk factors for Down syndrome in Jordan. , 2011, Genetic testing and molecular biomarkers.

[41]  Enzo Grossi,et al.  Polymorphisms in folate-metabolizing genes, chromosome damage, and risk of Down syndrome in Italian women: identification of key factors using artificial neural networks , 2010, BMC Medical Genomics.

[42]  Lora J. H. Bean,et al.  Variation in folate pathway genes contributes to risk of congenital heart defects among individuals with Down syndrome , 2010, Genetic epidemiology.

[43]  S. Ristić,et al.  Functional Inference of Methylenetetrahydrofolate Reductase Gene Polymorphisms on Enzyme Stability as a Potential Risk Factor for Down Syndrome in Croatia , 2010, Disease markers.

[44]  Sujoy Ghosh,et al.  Chromosome 21 non-disjunction and Down syndrome birth in an Indian cohort: analysis of incidence and aetiology from family linkage data. , 2010, Genetics research.

[45]  Hui Liu,et al.  [Folate gene polymorphism and the risk of Down syndrome pregnancies in young Chinese women]. , 2010, Yi chuan = Hereditas.

[46]  E. Bandinelli,et al.  Evaluation of C677T and A1298C polymorphisms of the MTHFR gene as maternal risk factors for Down syndrome and congenital heart defects , 2009, American journal of medical genetics. Part A.

[47]  F. Coppedè.  The complex relationship between folate/homocysteine metabolism and risk of Down syndrome. , 2009, Mutation research.

[48]  M. Valsecchi,et al.  Maternal polymorphisms for methyltetrahydrofolate reductase and methionine synthetase reductase and risk of children with Down syndrome. , 2009, American journal of obstetrics and gynecology.

[49]  K. Satyamoorthy,et al.  MTHFR Gene variants C677T, A1298C and association with Down syndrome: A Case-control study from South India , 2009, Indian journal of human genetics.

[50]  F. Coppedè,et al.  Association of maternal polymorphisms in folate metabolizing genes with chromosome damage and risk of Down syndrome offspring , 2009, Neuroscience Letters.

[51]  C. Santos-Rebouças,et al.  The impact of Folate Pathway Polymorphisms Combined to Nutritional Deficiency As a Maternal Predisposition Factor for Down Syndrome , 2008, Disease markers.

[52]  R. Pandey,et al.  Prevalence of MTHFR C677T polymorphism in north Indian mothers having babies with Trisomy 21 Down syndrome. , 2008, Down's syndrome, research and practice : the journal of the Sarah Duffen Centre.

[53]  M L Martínez-Frías,et al.  The biochemical structure and function of methylenetetrahydrofolate reductase provide the rationale to interpret the epidemiological results on the risk for infants with Down syndrome , 2008, American journal of medical genetics. Part A.

[54]  F. Qiao,et al.  Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome in China , 2008, Journal of Zhejiang University SCIENCE B.

[55]  N. Meguid,et al.  MTHFR Genetic Polymorphism As a Risk Factor in Egyptian Mothers with Down Syndrome Children , 2007, Disease markers.

[56]  E. Zintzaras.  Maternal gene polymorphisms involved in folate metabolism and risk of Down syndrome offspring: a meta-analysis , 2007, Journal of Human Genetics.

[57]  F. Coppedè,et al.  Polymorphisms in folate and homocysteine metabolizing genes and chromosome damage in mothers of Down syndrome children , 2007, American journal of medical genetics. Part A.

[58]  S. Vollset,et al.  Functional inference of the methylenetetrahydrofolate reductase 677 C > T and 1298A > C polymorphisms from a large-scale epidemiological study , 2007, Human Genetics.

[59]  P. Mastroiacovo,et al.  Analysis of seven maternal polymorphisms of genes involved in homocysteine/folate metabolism and risk of Down syndrome offspring , 2006, Genetics in Medicine.

[60]  F. Coppedè,et al.  Folate gene polymorphisms and the risk of Down syndrome pregnancies in young Italian women , 2006, American journal of medical genetics. Part A.

[61]  R. Raman,et al.  MTHFR C677T and A1298C polymorphisms are risk factors for Down's syndrome in Indian mothers , 2006, Journal of Human Genetics.

[62]  J. Annichino-Bizzacchi,et al.  Methylenetetrahydrofolate reductase gene polymorphisms and their association with trisomy 21 , 2005, Prenatal diagnosis.

[63]  S. J. James,et al.  No association between common polymorphisms in genes of folate and homocysteine metabolism and the risk of Down's syndrome among French mothers , 2005, British Journal of Nutrition.

[64]  D. Brunoni,et al.  Relationship between polymorphisms in genes involved in homocysteine metabolism and maternal risk for Down syndrome in Brazil , 2005, American journal of medical genetics. Part A.

[65]  M. Fenech,et al.  Folate deficiency induces aneuploidy in human lymphocytes in vitro-evidence using cytokinesis-blocked cells and probes specific for chromosomes 17 and 21. , 2004, Mutation research.

[66]  Y. Alanay,et al.  Methylenetetrahydrofolate reductase enzyme polymorphisms as maternal risk for down syndrome among Turkish women , 2004, American journal of medical genetics. Part A.

[67]  Nathaniel Rothman,et al.  Assessing the Probability That a Positive Report is False: An Approach for Molecular Epidemiology Studies , 2004 .

[68]  P. Bosco,et al.  Methionine synthase (MTR) 2756 (A → G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome , 2003, American journal of medical genetics. Part A.

[69]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[70]  J. Oury,et al.  Methylenetetrahydrofolate Reductase Polymorphism in the Etiology of Down Syndrome , 2002, Pediatric Research.

[71]  V. Gatta,et al.  C677T mutation in the 5,10-MTHFR gene and risk of Down syndrome in Italy , 2002, European Journal of Human Genetics.

[72]  A. Parle‐McDermott,et al.  MTRR and MTHFR polymorphism: link to Down syndrome? , 2002, American journal of medical genetics.

[73]  S. Vollset,et al.  Biological and clinical implications of the MTHFR C677T polymorphism. , 2001, Trends in pharmacological sciences.

[74]  R. Rozen,et al.  Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome. , 2000, American journal of human genetics.

[75]  V. L. Wilson,et al.  Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. , 1999, The American journal of clinical nutrition.

[76]  R. Rozen,et al.  A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. , 1998, Molecular genetics and metabolism.

[77]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[78]  C. Begg,et al.  Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.

[79]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[80]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.

[81]  W. G. Cochran.  The combination of estimates from different experiments. , 1954 .

[82]  S. Agarwal,et al.  Do the MTHFR gene polymorphism and Down syndrome pregnancy association stands true? A case–control study of Indian population and meta-analysis , 2016 .

[83]  M. Erdal,et al.  Folate metabolism gene polymorphisms and risk for down syndrome offspring in Turkish women. , 2015, Genetic testing and molecular biomarkers.

[84]  A. Sameer,et al.  Folate: metabolism, genes, polymorphisms and the associated diseases. , 2014, Gene.

[85]  S. Elsayed,et al.  Maternal MTHFR C677T genotype and septal defects in offspring with Down syndrome: A pilot study , 2014 .

[86]  P. Mohanty,et al.  GENETIC POLYMORPHISMS OF MTHFR (677T AND 1298C) AND HOMOCYSTEINE METABOLISM AS MATERNAL RISK FACTOR FOR DOWN 'S SYNDROME PATIENTS IN NORTH INDIAN POPULATION. , 2013 .